IBDEI0WN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15869,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,15869,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,15869,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,15870,0)
 ;;=V16.0^^81^949^7
 ;;^UTILITY(U,$J,358.3,15870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15870,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,15870,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,15870,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,15871,0)
 ;;=V16.1^^81^949^8
 ;;^UTILITY(U,$J,358.3,15871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15871,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,15871,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,15871,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,15872,0)
 ;;=V19.6^^81^949^1
 ;;^UTILITY(U,$J,358.3,15872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15872,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,15872,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,15872,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,15873,0)
 ;;=V18.2^^81^949^2
 ;;^UTILITY(U,$J,358.3,15873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15873,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,15873,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,15873,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,15874,0)
 ;;=V17.5^^81^949^4
 ;;^UTILITY(U,$J,358.3,15874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15874,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,15874,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,15874,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,15875,0)
 ;;=V17.7^^81^949^3
 ;;^UTILITY(U,$J,358.3,15875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15875,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,15875,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,15875,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,15876,0)
 ;;=V19.0^^81^949^5
 ;;^UTILITY(U,$J,358.3,15876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15876,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,15876,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,15876,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,15877,0)
 ;;=V16.3^^81^949^6
 ;;^UTILITY(U,$J,358.3,15877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15877,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,15877,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,15877,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,15878,0)
 ;;=V16.41^^81^949^9
 ;;^UTILITY(U,$J,358.3,15878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15878,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,15878,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,15878,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,15879,0)
 ;;=V16.42^^81^949^10
 ;;^UTILITY(U,$J,358.3,15879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15879,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,15879,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,15879,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,15880,0)
 ;;=V16.43^^81^949^11
 ;;^UTILITY(U,$J,358.3,15880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15880,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,15880,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,15880,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,15881,0)
 ;;=V19.5^^81^949^13
 ;;^UTILITY(U,$J,358.3,15881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15881,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,15881,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,15881,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,15882,0)
 ;;=V19.2^^81^949^14
 ;;^UTILITY(U,$J,358.3,15882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15882,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,15882,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;
 ;;$END ROU IBDEI0WN
